Study Site 8400184

Chicago, Illinois 60612

We've found

1 trials

at this facility

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Chicago, IL

Use our guide to learn which trials are right for you!